Cristina Tassorelli, MD, PhD

Director of the Headache Science Centre and of the Neurorehabilitative Unit at the IRCCS C. Mondino
University of Pavia, Pavia, Italy

Poster(s):

• (E 65) Unmet patient needs in migraine prevention: an international survey of real-world impact, preventive medication use, and drivers of discontinuation

• (T 02) Long-Term Safety, Tolerability, and Efficacy of Atogepant for the Preventive Treatment of Migraine: Final Results from a Phase 3, Open-Label, 156-Week, Long-Term Safety Extension Study

• (T 26) Consistent efficacy of eptinezumab across countries in adults with CM and MOH who also received patient education: Results from the RESOLUTION trial

• (T 29) Headache hours with severe pain intensity during long-term treatment with eptinezumab: Post hoc analysis of the DELIVER trial